TY - GEN
T1 - Leveraging Multiple Types of Domain Knowledge for Safe and Effective Drug Recommendation
AU - Wu, Jialun
AU - Qian, Buyue
AU - Li, Yang
AU - Gao, Zeyu
AU - Ju, Meizhi
AU - Yang, Yifan
AU - Zheng, Yefeng
AU - Gong, Tieliang
AU - Li, Chen
AU - Zhang, Xianli
N1 - Publisher Copyright:
© 2022 ACM.
PY - 2022/10/17
Y1 - 2022/10/17
N2 - Predicting drug combinations according to patients' electronic health records is an essential task in intelligent healthcare systems, which can assist clinicians in ordering safe and effective prescriptions. However, existing work either missed/underutilized the important information lying in the drug molecule structure in drug encoding or has insufficient control over Drug-Drug Interactions (DDIs) rates within the predictions. To address these limitations, we propose CSEDrug, which enhances the drug encoding and DDIs controlling by leveraging multi-faceted drug knowledge, including molecule structures of drugs, Synergistic DDIs (SDDIs), and Antagonistic DDIs (ADDIs). We integrate these types of knowledge into CSEDrug by a graph-based drug encoder and multiple loss functions, including a novel triplet learning loss and a comprehensive DDI controllable loss. We evaluate the performance of CSEDrug in terms of accuracy, effectiveness, and safety on the public MIMIC-III dataset. The experimental results demonstrate that CSEDrug outperforms several state-of-the-art methods and achieves a 2.93% and a 2.77% increase in the Jaccard similarity scores and F1 scores, meanwhile, a 0.68% reduction of the ADDI rate (safer drug combinations), and 0.69% improvement of the SDDI rate (more effective drug combinations).
AB - Predicting drug combinations according to patients' electronic health records is an essential task in intelligent healthcare systems, which can assist clinicians in ordering safe and effective prescriptions. However, existing work either missed/underutilized the important information lying in the drug molecule structure in drug encoding or has insufficient control over Drug-Drug Interactions (DDIs) rates within the predictions. To address these limitations, we propose CSEDrug, which enhances the drug encoding and DDIs controlling by leveraging multi-faceted drug knowledge, including molecule structures of drugs, Synergistic DDIs (SDDIs), and Antagonistic DDIs (ADDIs). We integrate these types of knowledge into CSEDrug by a graph-based drug encoder and multiple loss functions, including a novel triplet learning loss and a comprehensive DDI controllable loss. We evaluate the performance of CSEDrug in terms of accuracy, effectiveness, and safety on the public MIMIC-III dataset. The experimental results demonstrate that CSEDrug outperforms several state-of-the-art methods and achieves a 2.93% and a 2.77% increase in the Jaccard similarity scores and F1 scores, meanwhile, a 0.68% reduction of the ADDI rate (safer drug combinations), and 0.69% improvement of the SDDI rate (more effective drug combinations).
KW - deep learning
KW - drug recommendation
KW - electronic health records
KW - healthcare
UR - https://www.scopus.com/pages/publications/85140833036
U2 - 10.1145/3511808.3557380
DO - 10.1145/3511808.3557380
M3 - 会议稿件
AN - SCOPUS:85140833036
T3 - International Conference on Information and Knowledge Management, Proceedings
SP - 2169
EP - 2178
BT - CIKM 2022 - Proceedings of the 31st ACM International Conference on Information and Knowledge Management
PB - Association for Computing Machinery
T2 - 31st ACM International Conference on Information and Knowledge Management, CIKM 2022
Y2 - 17 October 2022 through 21 October 2022
ER -